Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Swine influenza - WHO holds emergency committee meeting

The Emergency Committee, established in compliance with the International Health Regulations (2005), held its second meeting on 27 April 2009.

27 Apr 2009

Swine flu reinforces the importance of preparing for emergencies

The American Public Health Association (APHA) urges the public to use the current swine flu outbreak as an opportunity to ensure that they and their families are prepared for potential pandemics, disasters or any other health emergencies that may arise.

27 Apr 2009

Green nanotechnology from tea

Researchers from the University of Missouri-Columbia report in the Journal of Materials Chemistry that chemicals in tea are the best yet discovered to make consistent, biologically safe gold nanoparticles. More importantly, these gold nanoparticles show promising anticancer properties.

27 Apr 2009

Update on swine flu in the United States and Mexico

As of 26 April 2009, the United States Government has reported 20 laboratory confirmed human cases of swine influenza A/H1N1 (8 in New York, 7 in California, 2 in Texas, 2 in Kansas and 1 in Ohio).

27 Apr 2009

Swine flu pandemic threat puts the world on high alert

An outbreak of swine flu in humans has health experts and officials around the world on high alert and there is great concern, as more countries report new cases of the disease, that the world may be on the brink of a pandemic.

27 Apr 2009

WHO response to swine influenza A(H1N1)

In response to cases of swine influenza A(H1N1), reported in Mexico and the United States of America, the Director-General convened a meeting of the Emergency Committee to assess the situation and advise her on appropriate responses.

26 Apr 2009

Swine influenza confirmed in the U.S.

The United States Government has reported seven confirmed human cases of Swine Influenza A/H1N1 in the USA (five in California and two in Texas) and nine suspect cases.

26 Apr 2009

Black-white differences in avoidable mortality in the United States, 1980-2005

Two-thirds of the difference between death rates among African Americans and Caucasians are now due to causes that could be prevented or cured, according to a new study appearing in the Journal of Epidemiology and Community Health.

23 Apr 2009

Natural plant cannabinoids reduce multi-drug resistant infections

Cannabis Science, Inc., Dr. Robert Melamede, PhD., Director and Chief Science Officer, reported to the Board on the current state of research into the use of natural plant cannabinoids to reduce the spread of drug-resistant bacteria, including methicillin-resistant Staphyloccus aureus (MRSA), and the prospects for development of topical whole-cannabis treatments.

23 Apr 2009

Lilly granted preliminary injunction to prevent launch of generic Raloxifene

Eli Lilly and Company has announced that the U.S. District Court for the Southern District of Indiana today issued a preliminary injunction to prevent the launch of a generic version of Lilly's medicine Evista (raloxifene HCl tablets) by Teva Pharmaceuticals until the Court renders its final ruling.

22 Apr 2009

Why an effective vaccine for HIV has proven so elusive

Some 25 years after the AIDS epidemic spawned a worldwide search for an effective vaccine against the human immunodeficiency virus (HIV), progress in the field seems to have effectively become stalled.

22 Apr 2009

Engineered antibody gives cancer the recognition it deserves

In concept, the human immune system has the power to destroy cancer cells with great specificity.

22 Apr 2009

The DNA proteome

The human genome complete sequencing project in 2003 revealed the enormous instruction manual necessary to define a human being.

22 Apr 2009

New insights into how to combat avian flu

An in-depth analysis of blood from patients recovering from the H5N1 avian influenza virus has provided important insights into how to combat the potentially lethal virus.

22 Apr 2009

Early treatment for hepatitis C offers a good chance of a cure

Australian researchers say as many as 70% of hepatitis C carriers can possibly be cured of the disease with early treatment - this is excellent news as hepatitis C, if left untreated can lead to serious liver disease.

22 Apr 2009

Repeated VR distraction reduces pain perception

Distraction through virtual-reality technology was found to reduce pain perceptions after repeated exposures in a University of Maryland study published in The Journal of Pain.

21 Apr 2009

NanoBio starts clinical trial for adjuvanted intranasal flu vaccine

NanoBio has announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for the Phase 1 clinical study of NB-1008, a seasonal influenza vaccine administered via a nasal dropper.

20 Apr 2009

Study looks at exposure to vibration in workplace

Speaking on April 19 at the Experimental Biology 2009 meeting in New Orleans, Dr. Kristine Krajnak, a team leader in the Engineering and Control Technologies Branch of the Health Effects Laboratory Division of NIOSH in Morgantown, West Virginia, describes results from the first study to directly link the different physical responses of tissue that occur with exposure to different vibration frequencies with biological mechanisms underlying the development of vascular dysfunction.

20 Apr 2009

Safety of bird flu drug Tamiflu in children questioned

A prominent Japanese researcher reporting on the bird flu drug Tamiflu says the drug may not be safe for children.

20 Apr 2009

DNA biosynthesis discovery could lead to better antibiotics

Combating several human pathogens, including some biological warfare agents, may one day become a bit easier thanks to research reported by a University of Iowa chemist and his colleagues in the April 16 issue of the journal Nature.

16 Apr 2009